HCA Healthcare (HCA) sees Q2 EPS USD 7.62 (exp. 7.47), Revenue 20.23bln (exp. 19.38bln); Lowers FY26 EPS view to USD 28.70-30.50 (prev. 29.10-31.50, exp. 30.19)
- Narrows FY26 revenue view to USD 77-79.5bln (prev. 76.5-80bln, exp. 78.58bln).
- Lowers FY26 adj. EBITDA view to USD 15.4-16.1bln (prev. 15.55-16.45bln).
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#HCA HOLDINGS INC#HCA.US#FOREX#EQUITIES#METALS#EU SESSION#US SESSION#HEALTH CARE FACILITIES#METALS & MINING#HEALTH CARE PROVIDERS & SERVICES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#HCA HEALTHCARE INC#HCA#DXY#US EQUITIES